Pfizer
New York, NY, USA
ROLE SUMMARY At Pfizer Oncology, our purpose is to Outdo Cancer by delivering transformative medicines that have the potential to meaningfully change outcomes for patients. Pfizer Oncology’s industry‑leading pipeline spans breast, genitourinary (GU), hematology, gastroenterology, and thoracic therapeutic areas, reflecting both scientific depth and sustained investment in areas of high unmet need. The US Precision Medicine/Thoracic Franchise is positioned for significant growth, supported by a differentiated thoracic portfolio that includes Sigvotatug Vedotin (SGN‑B6A / IB6), an investigational antibody‑drug conjugate (ADC) under development for the treatment of non‑small cell lung cancer (NSCLC). Sigvotatug Vedotin represents a potential next‑generation approach within thoracic oncology, reinforcing Pfizer’s commitment to advancing precision‑based strategies and expanding therapeutic options in a highly competitive and evolving landscape. This asset, alongside a strong...